These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 1695627

  • 1. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC, Myones BL, Frazier B, Holers VM.
    J Biol Chem; 1990 Jul 25; 265(21):12293-9. PubMed ID: 1695627
    [Abstract] [Full Text] [Related]

  • 2. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
    Molina H, Brenner C, Jacobi S, Gorka J, Carel JC, Kinoshita T, Holers VM.
    J Biol Chem; 1991 Jul 05; 266(19):12173-9. PubMed ID: 1712014
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.
    Moore MD, Cannon MJ, Sewall A, Finlayson M, Okimoto M, Nemerow GR.
    J Virol; 1991 Jul 05; 65(7):3559-65. PubMed ID: 1645784
    [Abstract] [Full Text] [Related]

  • 4. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W.
    EMBO J; 1991 Apr 05; 10(4):919-26. PubMed ID: 1849076
    [Abstract] [Full Text] [Related]

  • 5. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR.
    J Virol; 1987 May 05; 61(5):1416-20. PubMed ID: 3033269
    [Abstract] [Full Text] [Related]

  • 6. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC, Frazier B, Ley TJ, Holers VM.
    J Immunol; 1989 Aug 01; 143(3):923-30. PubMed ID: 2473114
    [Abstract] [Full Text] [Related]

  • 7. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT.
    J Exp Med; 1988 Mar 01; 167(3):1047-66. PubMed ID: 2832506
    [Abstract] [Full Text] [Related]

  • 8. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
    Ahearn JM, Fearon DT.
    Adv Immunol; 1989 Mar 01; 46():183-219. PubMed ID: 2551147
    [No Abstract] [Full Text] [Related]

  • 9. Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2.
    Martin DR, Yuryev A, Kalli KR, Fearon DT, Ahearn JM.
    J Exp Med; 1991 Dec 01; 174(6):1299-311. PubMed ID: 1660522
    [Abstract] [Full Text] [Related]

  • 10. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.
    Cantaloube JF, Piechaczyk M, Calender A, Lenoir G, Minty A, Carrière D, Fischer E, Poncelet P.
    Eur J Immunol; 1990 Feb 01; 20(2):409-16. PubMed ID: 1690137
    [Abstract] [Full Text] [Related]

  • 11. Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2).
    Moore MD, DiScipio RG, Cooper NR, Nemerow GR.
    J Biol Chem; 1989 Dec 05; 264(34):20576-82. PubMed ID: 2555366
    [Abstract] [Full Text] [Related]

  • 12. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF, Goldmacher VS, Lambert JM, Schlossman SF.
    J Immunol; 1986 Aug 15; 137(4):1387-91. PubMed ID: 3016095
    [Abstract] [Full Text] [Related]

  • 13. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
    Mold C, Cooper NR, Nemerow GR.
    J Immunol; 1986 Jun 01; 136(11):4140-5. PubMed ID: 3009615
    [Abstract] [Full Text] [Related]

  • 14. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.
    Lowell CA, Klickstein LB, Carter RH, Mitchell JA, Fearon DT, Ahearn JM.
    J Exp Med; 1989 Dec 01; 170(6):1931-46. PubMed ID: 2479703
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
    Guthridge JM, Young K, Gipson MG, Sarrias MR, Szakonyi G, Chen XS, Malaspina A, Donoghue E, James JA, Lambris JD, Moir SA, Perkins SJ, Holers VM.
    J Immunol; 2001 Nov 15; 167(10):5758-66. PubMed ID: 11698449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.